Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Clinical pharmacology of the loop diuretics furosemide and bumetanide in neonates and infants.

Pacifici GM.

Paediatr Drugs. 2012 Aug 1;14(4):233-46. doi: 10.2165/11596620-000000000-00000. Review.

PMID:
22702741
2.

Clinical pharmacology of furosemide in neonates: a review.

Pacifici GM.

Pharmaceuticals (Basel). 2013 Sep 5;6(9):1094-129. doi: 10.3390/ph6091094.

3.

Clinical pharmacology of indomethacin in preterm infants: implications in patent ductus arteriosus closure.

Pacifici GM.

Paediatr Drugs. 2013 Oct;15(5):363-76. doi: 10.1007/s40272-013-0031-7. Review.

PMID:
23754139
4.

Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.

Ohlsson A, Walia R, Shah S.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD003481. doi: 10.1002/14651858.CD003481.pub3. Review. Update in: Cochrane Database Syst Rev. 2010;(4):CD003481.

PMID:
18254020
5.

Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants.

Ohlsson A, Walia R, Shah SS.

Cochrane Database Syst Rev. 2015 Feb 18;(2):CD003481. doi: 10.1002/14651858.CD003481.pub6. Review.

PMID:
25692606
6.

Evaluation of furosemide regimens in neonates treated with extracorporeal membrane oxygenation.

van der Vorst MM, Wildschut E, Houmes RJ, Gischler SJ, Kist-van Holthe JE, Burggraaf J, van der Heijden AJ, Tibboel D.

Crit Care. 2006;10(6):R168.

7.

Furosemide for symptomatic patent ductus arteriosus in indomethacin-treated infants.

Brion LP, Campbell DE.

Cochrane Database Syst Rev. 2001;(3):CD001148. Review.

PMID:
11686979
8.

Furosemide for symptomatic patent ductus arteriosus in indomethacin-treated infants.

Brion LP, Campbell DE.

Cochrane Database Syst Rev. 2000;(2):CD001148. Review. Update in: Cochrane Database Syst Rev. 2001;(3):CD001148.

PMID:
10796253
9.

A comprehensive review of the loop diuretics: should furosemide be first line?

Wargo KA, Banta WM.

Ann Pharmacother. 2009 Nov;43(11):1836-47. doi: 10.1345/aph.1M177. Epub 2009 Oct 20. Review.

PMID:
19843838
10.
11.

Ibuprofen for the treatment of a patent ductus arteriosus in preterm and/or low birth weight infants.

Ohlsson A, Walia R, Shah S.

Cochrane Database Syst Rev. 2003;(2):CD003481. Review. Update in: Cochrane Database Syst Rev. 2005;(4):CD003481.

PMID:
12804469
12.

Continuous infusion versus intermittent bolus doses of indomethacin for patent ductus arteriosus closure in symptomatic preterm infants.

Görk AS, Ehrenkranz RA, Bracken MB.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD006071. doi: 10.1002/14651858.CD006071.pub2. Review.

PMID:
18254092
13.

The clinical pharmacology of loop diuretics in the pediatric patient.

Eades SK, Christensen ML.

Pediatr Nephrol. 1998 Sep;12(7):603-16. Review.

PMID:
9761364
14.

An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study.

Hirt D, Van Overmeire B, Treluyer JM, Langhendries JP, Marguglio A, Eisinger MJ, Schepens P, Urien S.

Br J Clin Pharmacol. 2008 May;65(5):629-36. doi: 10.1111/j.1365-2125.2008.03118.x. Epub 2008 Feb 27.

15.
16.

Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.

Ohlsson A, Walia R, Shah SS.

Cochrane Database Syst Rev. 2013 Apr 30;(4):CD003481. doi: 10.1002/14651858.CD003481.pub5. Review. Update in: Cochrane Database Syst Rev. 2015;(2):CD003481.

PMID:
23633310
17.

Furosemide does not prevent indomethacin-induced renal side effects in preterm infants.

Romagnoli C, Zecca E, Papacci P, De Carolis MP, Giannini R, Gallini F, Tortorolo G.

Clin Pharmacol Ther. 1997 Aug;62(2):181-6.

PMID:
9284854
18.

Comparative study of the efficacy and safety of paracetamol, ibuprofen, and indomethacin in closure of patent ductus arteriosus in preterm neonates.

El-Mashad AE, El-Mahdy H, El Amrousy D, Elgendy M.

Eur J Pediatr. 2017 Feb;176(2):233-240. doi: 10.1007/s00431-016-2830-7. Epub 2016 Dec 21.

PMID:
28004188
19.
20.

Supplemental Content

Support Center